 | • レポートコード：QY20ST-06632 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の免疫刺激アジュバント市場について種類別（水酸化アルミニウムアジュバント、ミョウバンアジュバント、リポソーム、その他）、用途別（病院、医療センター、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・免疫刺激アジュバント市場の概要 ・世界の主要地域別免疫刺激アジュバント市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の免疫刺激アジュバント市場規模2015-2026：種類別（水酸化アルミニウムアジュバント、ミョウバンアジュバント、リポソーム、その他） ・世界の免疫刺激アジュバント市場規模2015-2026：用途別（病院、医療センター、その他） ・免疫刺激アジュバントの北米市場規模2015-2020 ・免疫刺激アジュバントのヨーロッパ市場規模2015-2020 ・免疫刺激アジュバントの中国市場規模2015-2020 ・免疫刺激アジュバントの日本市場規模2015-2020 ・免疫刺激アジュバントの東南アジア市場規模2015-2020 ・免疫刺激アジュバントのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・免疫刺激アジュバントの製造コスト分析 ・販売チャネル、流通業者、顧客 ・免疫刺激アジュバントの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Immunostimulatory Adjuvants Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Immunostimulatory Adjuvants market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Immunostimulatory Adjuvants market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Immunostimulatory Adjuvants industry.
Based on our recent survey, we have several different scenarios about the Immunostimulatory Adjuvants YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Immunostimulatory Adjuvants will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Immunostimulatory Adjuvants market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Immunostimulatory Adjuvants market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Immunostimulatory Adjuvants market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Immunostimulatory Adjuvants market. The report also includes nautical information, where it shows Immunostimulatory Adjuvants market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Immunostimulatory Adjuvants market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Immunostimulatory Adjuvants market.
Geographical Analysis:
Based on region, the global Immunostimulatory Adjuvants market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Immunostimulatory Adjuvants market are
Bayer
Adjuvance Technologies
Vical
Allergy Therapeutics
BioCentury
…
Segment by Type
Aluminum Hydroxide Adjuvant
Alum Adjuvant
Liposomes
Others
Segment by Application
Hospitals
Medical Centers
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Immunostimulatory Adjuvants market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Immunostimulatory Adjuvants market.
• The market share of the global Immunostimulatory Adjuvants market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Immunostimulatory Adjuvants market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Immunostimulatory Adjuvants market.
1 Immunostimulatory Adjuvants Market Overview
1.1 Immunostimulatory Adjuvants Product Scope
1.2 Immunostimulatory Adjuvants Segment by Type
1.2.1 Global Immunostimulatory Adjuvants Sales by Type (2020-2026)
1.2.2 Aluminum Hydroxide Adjuvant
1.2.3 Alum Adjuvant
1.2.4 Liposomes
1.2.5 Others
1.3 Immunostimulatory Adjuvants Segment by Application
1.3.1 Global Immunostimulatory Adjuvants Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Immunostimulatory Adjuvants Market Estimates and Forecasts (2015-2026)
1.4.1 Global Immunostimulatory Adjuvants Sales Growth Rate (2015-2026)
1.4.2 Global Immunostimulatory Adjuvants Revenue and Growth Rate (2015-2026)
1.4.3 Global Immunostimulatory Adjuvants Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Immunostimulatory Adjuvants Industry Impact
1.5.1 How the Covid-19 is Affecting the Immunostimulatory Adjuvants Industry
1.5.1.1 Immunostimulatory Adjuvants Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Immunostimulatory Adjuvants Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Immunostimulatory Adjuvants Players to Combat Covid-19 Impact
2 Immunostimulatory Adjuvants Estimate and Forecast by Region
2.1 Global Immunostimulatory Adjuvants Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Immunostimulatory Adjuvants Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Immunostimulatory Adjuvants Sales Market Share by Region (2015-2020)
2.2.2 Global Immunostimulatory Adjuvants Revenue Market Share by Region (2015-2020)
2.3 Global Immunostimulatory Adjuvants Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Immunostimulatory Adjuvants Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Immunostimulatory Adjuvants Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Immunostimulatory Adjuvants Estimates and Projections (2015-2026)
2.4.2 Europe Immunostimulatory Adjuvants Estimates and Projections (2015-2026)
2.4.3 China Immunostimulatory Adjuvants Estimates and Projections (2015-2026)
2.4.4 Japan Immunostimulatory Adjuvants Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Immunostimulatory Adjuvants Estimates and Projections (2015-2026)
2.4.6 India Immunostimulatory Adjuvants Estimates and Projections (2015-2026)
3 Global Immunostimulatory Adjuvants Competition Landscape by Players
3.1 Global Top Immunostimulatory Adjuvants Players by Sales (2015-2020)
3.2 Global Top Immunostimulatory Adjuvants Players by Revenue (2015-2020)
3.3 Global Immunostimulatory Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunostimulatory Adjuvants as of 2019)
3.4 Global Immunostimulatory Adjuvants Average Price by Company (2015-2020)
3.5 Manufacturers Immunostimulatory Adjuvants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Immunostimulatory Adjuvants Players (Opinion Leaders)
4 Global Immunostimulatory Adjuvants Market Size by Type
4.1 Global Immunostimulatory Adjuvants Historic Market Review by Type (2015-2020)
4.1.1 Global Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
4.1.2 Global Immunostimulatory Adjuvants Revenue Market Share by Type (2015-2020)
4.1.3 Global Immunostimulatory Adjuvants Price by Type (2014-2020)
4.2 Global Immunostimulatory Adjuvants Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Immunostimulatory Adjuvants Sales Forecast by Type (2021-2026)
4.2.2 Global Immunostimulatory Adjuvants Revenue Forecast by Type (2021-2026)
4.2.3 Global Immunostimulatory Adjuvants Price Forecast by Type (2021-2026)
5 Global Immunostimulatory Adjuvants Market Size by Application
5.1 Global Immunostimulatory Adjuvants Historic Market Review by Application (2015-2020)
5.1.1 Global Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
5.1.2 Global Immunostimulatory Adjuvants Revenue Market Share by Application (2015-2020)
5.1.3 Global Immunostimulatory Adjuvants Price by Application (2015-2020)
5.2 Global Immunostimulatory Adjuvants Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Immunostimulatory Adjuvants Sales Forecast by Application (2021-2026)
5.2.2 Global Immunostimulatory Adjuvants Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunostimulatory Adjuvants Price Forecast by Application (2021-2026)
3 North America Immunostimulatory Adjuvants Market Facts & Figures
3.2 North America Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
3.3 North America Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
3.4 North America Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
4 Europe Immunostimulatory Adjuvants Market Facts & Figures
4.2 Europe Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
4.3 Europe Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
4.4 Europe Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
5 China Immunostimulatory Adjuvants Market Facts & Figures
5.2 China Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
5.3 China Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
5.4 China Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
6 Japan Immunostimulatory Adjuvants Market Facts & Figures
6.2 Japan Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
6.3 Japan Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
6.4 Japan Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
7 Southeast Asia Immunostimulatory Adjuvants Market Facts & Figures
7.2 Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
8 India Immunostimulatory Adjuvants Market Facts & Figures
8.2 India Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
8.3 India Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
8.4 India Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Immunostimulatory Adjuvants Business
12.1 Bayer
12.1.1 Bayer Immunostimulatory Adjuvants Corporation Information
12.1.2 Bayer Immunostimulatory Adjuvants Business Overview and Total Revenue
12.1.3 Bayer Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Immunostimulatory Adjuvants Products Offered
12.1.5 Bayer Recent Development
12.2 Adjuvance Technologies
12.2.1 Adjuvance Technologies Immunostimulatory Adjuvants Corporation Information
12.2.2 Adjuvance Technologies Immunostimulatory Adjuvants Business Overview and Total Revenue
12.2.3 Adjuvance Technologies Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Adjuvance Technologies Immunostimulatory Adjuvants Products Offered
12.2.5 Adjuvance Technologies Recent Development
12.3 Vical
12.3.1 Vical Immunostimulatory Adjuvants Corporation Information
12.3.2 Vical Immunostimulatory Adjuvants Business Overview and Total Revenue
12.3.3 Vical Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Vical Immunostimulatory Adjuvants Products Offered
12.3.5 Vical Recent Development
12.4 Allergy Therapeutics
12.4.1 Allergy Therapeutics Immunostimulatory Adjuvants Corporation Information
12.4.2 Allergy Therapeutics Immunostimulatory Adjuvants Business Overview and Total Revenue
12.4.3 Allergy Therapeutics Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Allergy Therapeutics Immunostimulatory Adjuvants Products Offered
12.4.5 Allergy Therapeutics Recent Development
12.5 BioCentury
12.5.1 BioCentury Immunostimulatory Adjuvants Corporation Information
12.5.2 BioCentury Immunostimulatory Adjuvants Business Overview and Total Revenue
12.5.3 BioCentury Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BioCentury Immunostimulatory Adjuvants Products Offered
12.5.5 BioCentury Recent Development
…
13 Immunostimulatory Adjuvants Manufacturing Cost Analysis
13.1 Immunostimulatory Adjuvants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Immunostimulatory Adjuvants
13.4 Immunostimulatory Adjuvants Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Immunostimulatory Adjuvants Distributors List
14.3 Immunostimulatory Adjuvants Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Immunostimulatory Adjuvants Sales (K Pieces) Growth Rate by Type (2020-2026)
Table 2. Global Immunostimulatory Adjuvants Sales (K Pieces) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Immunostimulatory Adjuvants Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Immunostimulatory Adjuvants Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Immunostimulatory Adjuvants Players to Combat Covid-19 Impact
Table 8. Global Market Immunostimulatory Adjuvants Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Immunostimulatory Adjuvants Sales (K Pieces) by Region (2015-2020)
Table 10. Global Immunostimulatory Adjuvants Sales Market Share by Region (2015-2020)
Table 11. Global Immunostimulatory Adjuvants Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Immunostimulatory Adjuvants Revenue Share by Region (2015-2020)
Table 13. Global Immunostimulatory Adjuvants Sales (K Pieces) Forecast by Region (2021-2026)
Table 14. Global Immunostimulatory Adjuvants Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Immunostimulatory Adjuvants Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Immunostimulatory Adjuvants Revenue Share Forecast by Region (2021-2026)
Table 17. Global Immunostimulatory Adjuvants (K Pieces) of Key Companies (2015-2020)
Table 18. Global Immunostimulatory Adjuvants Sales Share by Company (2015-2020)
Table 19. Global Immunostimulatory Adjuvants Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Immunostimulatory Adjuvants Revenue Share by Company (2015-2020)
Table 21. Global Immunostimulatory Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunostimulatory Adjuvants as of 2019)
Table 22. Global Immunostimulatory Adjuvants Average Price (USD/Piece) of Key Company (2015-2020)
Table 23. Manufacturers Immunostimulatory Adjuvants Manufacturing Sites and Area Served
Table 24. Manufacturers Immunostimulatory Adjuvants Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Immunostimulatory Adjuvants Players
Table 27. Global Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 28. Global Immunostimulatory Adjuvants Sales Share by Type (2015-2020)
Table 29. Global Immunostimulatory Adjuvants Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Immunostimulatory Adjuvants Price (K Pieces) by Type (2015-2020)
Table 31. Global Immunostimulatory Adjuvants Sales Share by Type (2021-2026)
Table 32. Global Immunostimulatory Adjuvants Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Immunostimulatory Adjuvants Revenue Share by Type (2021-2026)
Table 34. Global Immunostimulatory Adjuvants Price (K Pieces) by Type (2021-2026)
Table 35. Global Immunostimulatory Adjuvants Sales (K Pieces) by Application (2015-2020)
Table 36. Global Immunostimulatory Adjuvants Sales Share by Application (2015-2020)
Table 37. Global Immunostimulatory Adjuvants Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Immunostimulatory Adjuvants Price (K Pieces) by Application (2015-2020)
Table 39. Global Immunostimulatory Adjuvants Sales (K Pieces) by Application (2021-2026)
Table 40. Global Immunostimulatory Adjuvants Sales Share by Application (2021-2026)
Table 41. Global Immunostimulatory Adjuvants Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Immunostimulatory Adjuvants Revenue Share by Application (2021-2026)
Table 43. Global Immunostimulatory Adjuvants Price (K Pieces) by Application (2021-2026)
Table 44. United States Immunostimulatory Adjuvants Sales (K Pieces) by Company (2015-2020)
Table 45. United States Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
Table 46. United States Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 47. United States Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 48. United States Immunostimulatory Adjuvants Sales (K Pieces) by Application (2015-2020)
Table 49. United States Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
Table 50. Europe Immunostimulatory Adjuvants Sales (K Pieces) by Company (2015-2020)
Table 51. Europe Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
Table 52. Europe Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 53. Europe Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 54. Europe Immunostimulatory Adjuvants Sales (K Pieces) by Application (2015-2020)
Table 55. Europe Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 56. China Immunostimulatory Adjuvants Sales (K Pieces) by Company (2015-2020)
Table 57. China Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
Table 58. China Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 59. China Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 60. China Immunostimulatory Adjuvants Sales (K Pieces) by Application (2015-2020)
Table 61. China Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
Table 62. Japan Immunostimulatory Adjuvants Sales (K Pieces) by Company (2015-2020)
Table 63. Japan Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
Table 64. Japan Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 65. Japan Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 66. Japan Immunostimulatory Adjuvants Sales (K Pieces) by Application (2015-2020)
Table 67. Japan Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Immunostimulatory Adjuvants Sales (K Pieces) by Company (2015-2020)
Table 69. Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 71. Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 73. Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
Table 74. India Immunostimulatory Adjuvants Sales (K Pieces) by Company (2015-2020)
Table 75. India Immunostimulatory Adjuvants Sales Market Share by Company (2015-2020)
Table 76. India Immunostimulatory Adjuvants Sales (K Pieces) by Type (2015-2020)
Table 77. India Immunostimulatory Adjuvants Sales Market Share by Type (2015-2020)
Table 78. India Immunostimulatory Adjuvants Sales (K Pieces) by Application (2015-2020)
Table 79. India Immunostimulatory Adjuvants Sales Market Share by Application (2015-2020)
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 83. Bayer Immunostimulatory Adjuvants Product
Table 84. Bayer Recent Development
Table 85. Adjuvance Technologies Corporation Information
Table 86. Adjuvance Technologies Description and Business Overview
Table 87. Adjuvance Technologies Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 88. Adjuvance Technologies Immunostimulatory Adjuvants Product
Table 89. Adjuvance Technologies Recent Development
Table 90. Vical Corporation Information
Table 91. Vical Description and Business Overview
Table 92. Vical Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 93. Vical Immunostimulatory Adjuvants Product
Table 94. Vical Recent Development
Table 95. Allergy Therapeutics Corporation Information
Table 96. Allergy Therapeutics Description and Business Overview
Table 97. Allergy Therapeutics Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 98. Allergy Therapeutics Immunostimulatory Adjuvants Product
Table 99. Allergy Therapeutics Recent Development
Table . BioCentury Corporation Information
Table . BioCentury Description and Business Overview
Table . BioCentury Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table . BioCentury Immunostimulatory Adjuvants Product
Table . BioCentury Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Immunostimulatory Adjuvants Distributors List
Table 108. Immunostimulatory Adjuvants Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunostimulatory Adjuvants Product Picture
Figure 2. Global Immunostimulatory Adjuvants Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Immunostimulatory Adjuvants Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Medical Centers Examples
Figure 8. Others Examples
Figure 9. Global Immunostimulatory Adjuvants Sales (K Pieces) Growth Rate (2015-2026)
Figure 10. Global Immunostimulatory Adjuvants Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Immunostimulatory Adjuvants Price Trends Growth Rate (2015-2026) (USD/Piece)
Figure 12. Global Immunostimulatory Adjuvants Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Immunostimulatory Adjuvants Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Immunostimulatory Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Immunostimulatory Adjuvants Sales (K Pieces) Growth Rate (2015-2026)
Figure 16. Europe Immunostimulatory Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Immunostimulatory Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Immunostimulatory Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Immunostimulatory Adjuvants Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Immunostimulatory Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Immunostimulatory Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Immunostimulatory Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Immunostimulatory Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Immunostimulatory Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Immunostimulatory Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Immunostimulatory Adjuvants Players Market Share by Revenue in Immunostimulatory Adjuvants 2015 & 2019
Figure 27. Immunostimulatory Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Immunostimulatory Adjuvants Revenue Share by Type (2015-2020)
Figure 29. Global Immunostimulatory Adjuvants Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Immunostimulatory Adjuvants Revenue Share by Application (2015-2020)
Figure 31. Global Immunostimulatory Adjuvants Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 33. United States Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 34. Europe Immunostimulatory Adjuvants Sales Market Share by Company in 2019
Figure 35. Europe Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 36. Europe Immunostimulatory Adjuvants Sales Market Share by Application in 2019
Figure 37. China Immunostimulatory Adjuvants Sales Market Share by Company in 2019
Figure 38. China Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 39. China Immunostimulatory Adjuvants Sales Market Share by Application in 2019
Figure 40. Japan Immunostimulatory Adjuvants Sales Market Share by Company in 2019
Figure 41. Japan Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 42. Japan Immunostimulatory Adjuvants Sales Market Share by Application in 2019
Figure 43. Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Company in 2019
Figure 44. Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 45. Southeast Asia Immunostimulatory Adjuvants Sales Market Share by Application in 2019
Figure 46. India Immunostimulatory Adjuvants Sales Market Share by Company in 2019
Figure 47. India Immunostimulatory Adjuvants Sales Market Share by Type in 2019
Figure 48. India Immunostimulatory Adjuvants Sales Market Share by Application in 2019
Figure 49. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Adjuvance Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Vical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Allergy Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioCentury Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Immunostimulatory Adjuvants
Figure 56. Manufacturing Process Analysis of Immunostimulatory Adjuvants
Figure 57. Immunostimulatory Adjuvants Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
超微細水酸化アルミニウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ultra-Fine Aluminum Hydroxide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ultra-Fine Alum…- アンモニアミョウバンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Ammonia Alum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 水酸化銅殺菌剤の世界市場レポート2020 Copper hydroxide bactericide is used for the sterilization of citrus, rice, peanut and cruciferous vegetables. Copper hydroxide is one of the most widely used copper funigicide, Market Analysis and Insights: Global Copper Hydroxide Fungicides Market Since the COVID-19 virus outbreak in December 2019…
- 水酸化亜鉛の世界市場レポート2020 Market Analysis and Insights: Global Zinc Hydroxide Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019…
- バッテリー用水酸化リチウムの世界市場レポート2020 A recently published report by QY Research titled Global Battery Grade Lithium Hydroxide Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically prov…